Precigen (Germany) Today
| I5X Stock | EUR 0.85 0.07 8.97% |
Performance0 of 100
| Odds Of DistressOver 61
|
Precigen is trading at 0.85 as of the 25th of November 2024. This is a 8.97 percent increase since the beginning of the trading day. The stock's lowest day price was 0.85. Precigen has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Precigen are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. PRECIGEN INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. The company has 251.01 M outstanding shares. More on Precigen
Moving together with Precigen Stock
Moving against Precigen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Precigen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Precigen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Precigen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Helen Sabzevari |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Precigen (I5X) is traded on Frankfurt Exchange in Germany and employs 456 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 267.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Precigen's market, we take the total number of its shares issued and multiply it by Precigen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Precigen classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 251.01 M outstanding shares.
Precigen has accumulated about 105.69 M in cash with (55.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Check Precigen Probability Of Bankruptcy
Ownership AllocationPrecigen owns a total of 251.01 Million outstanding shares. Over half of Precigen's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Precigen. Please watch out for any change in the institutional holdings of Precigen as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Precigen Ownership Details
Precigen Risk Profiles
Although Precigen's alpha and beta are two of the key measurements used to evaluate Precigen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.95 | |||
| Standard Deviation | 3.8 | |||
| Variance | 14.45 | |||
| Risk Adjusted Performance | (0.03) |
Precigen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Precigen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Precigen Corporate Directors
| Steven Frank | Independent Director | Profile | |
| Jeffrey Kindler | Independent Director | Profile | |
| Cesar Alvarez | Independent Director | Profile | |
| Vinita Gupta | Independent Director | Profile |
Additional Information and Resources on Investing in Precigen Stock
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Precigen Stock please use our How to Invest in Precigen guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.